Aethlon Medical, Inc. (AEMD)
USD 0.33
(-5.27%)
USD 0.33
(-5.27%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 2.47 Million USD | 1.43% |
| 2023 | 2.44 Million USD | 0.75% |
| 2022 | 2.42 Million USD | 76.45% |
| 2021 | 1.37 Million USD | 23.87% |
| 2020 | 1.11 Million USD | -39.13% |
| 2019 | 1.82 Million USD | 38.27% |
| 2018 | 1.31 Million USD | 16.64% |
| 2017 | 1.13 Million USD | 7.26% |
| 2016 | 1.05 Million USD | 44.59% |
| 2015 | 729.2 Thousand USD | -95.56% |
| 2014 | 16.42 Million USD | 70.37% |
| 2013 | 9.64 Million USD | -4.87% |
| 2012 | 10.13 Million USD | 54.89% |
| 2011 | 6.54 Million USD | 29.61% |
| 2010 | 5.04 Million USD | 21.74% |
| 2009 | 4.14 Million USD | 8.83% |
| 2008 | 3.81 Million USD | -50.55% |
| 2007 | 7.7 Million USD | 176.24% |
| 2006 | 2.78 Million USD | -17.17% |
| 2005 | 3.36 Million USD | -14.47% |
| 2004 | 3.93 Million USD | -2.17% |
| 2003 | 4.02 Million USD | 26.9% |
| 2002 | 3.17 Million USD | -15.44% |
| 2001 | 3.74 Million USD | 84.45% |
| 2000 | 2.03 Million USD | 158.47% |
| 1999 | 786.56 Thousand USD | 39645.78% |
| 1998 | 1979.00 USD | 465.43% |
| 1997 | 350.00 USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 2.5 Million USD | -6.79% |
| 2024 Q4 | 2.47 Million USD | -12.24% |
| 2024 Q3 | 2.82 Million USD | 12.61% |
| 2024 FY | 2.47 Million USD | 1.43% |
| 2024 Q1 | 2.69 Million USD | 10.1% |
| 2023 Q2 | 3.17 Million USD | 43.71% |
| 2023 Q3 | 3.44 Million USD | 8.38% |
| 2023 FY | 2.44 Million USD | 0.75% |
| 2023 Q1 | 2.21 Million USD | -8.84% |
| 2023 Q4 | 2.44 Million USD | -29.04% |
| 2022 Q2 | 974.34 Thousand USD | -13.87% |
| 2022 Q1 | 1.13 Million USD | -17.74% |
| 2022 FY | 2.42 Million USD | 76.45% |
| 2022 Q4 | 2.42 Million USD | 78.83% |
| 2022 Q3 | 1.35 Million USD | 39.26% |
| 2021 Q2 | 1.48 Million USD | 20.13% |
| 2021 Q3 | 1.23 Million USD | -17.06% |
| 2021 Q4 | 1.37 Million USD | 11.3% |
| 2021 FY | 1.37 Million USD | 23.87% |
| 2021 Q1 | 1.24 Million USD | 11.7% |
| 2020 Q3 | 878.3 Thousand USD | -30.35% |
| 2020 Q4 | 1.11 Million USD | 26.41% |
| 2020 FY | 1.11 Million USD | -39.13% |
| 2020 Q1 | 1.91 Million USD | 4.98% |
| 2020 Q2 | 1.26 Million USD | -34.14% |
| 2019 FY | 1.82 Million USD | 38.27% |
| 2019 Q4 | 1.82 Million USD | 2.42% |
| 2019 Q1 | 1.34 Million USD | 1.8% |
| 2019 Q2 | 1.26 Million USD | -6.11% |
| 2019 Q3 | 1.78 Million USD | 41.23% |
| 2018 Q2 | 1.12 Million USD | -22.8% |
| 2018 Q4 | 1.31 Million USD | 14.98% |
| 2018 FY | 1.31 Million USD | 16.64% |
| 2018 Q1 | 1.45 Million USD | 29.03% |
| 2018 Q3 | 1.14 Million USD | 1.84% |
| 2017 Q2 | 1.08 Million USD | -0.14% |
| 2017 Q4 | 1.13 Million USD | 43.43% |
| 2017 FY | 1.13 Million USD | 7.26% |
| 2017 Q1 | 1.08 Million USD | 2.98% |
| 2017 Q3 | 788.51 Thousand USD | -27.27% |
| 2016 Q4 | 1.05 Million USD | 19.29% |
| 2016 FY | 1.05 Million USD | 44.59% |
| 2016 Q1 | 896.61 Thousand USD | 22.96% |
| 2016 Q2 | 828.94 Thousand USD | -7.55% |
| 2016 Q3 | 883.88 Thousand USD | 6.63% |
| 2015 Q3 | 1.86 Million USD | -57.48% |
| 2015 Q1 | 4.66 Million USD | -71.6% |
| 2015 FY | 729.2 Thousand USD | -95.56% |
| 2015 Q4 | 729.2 Thousand USD | -60.84% |
| 2015 Q2 | 4.37 Million USD | -6.15% |
| 2014 Q2 | 11.95 Million USD | 32.65% |
| 2014 Q1 | 9.01 Million USD | -6.49% |
| 2014 Q4 | 16.42 Million USD | 29.84% |
| 2014 FY | 16.42 Million USD | 70.37% |
| 2014 Q3 | 12.64 Million USD | 5.78% |
| 2013 Q3 | 7.62 Million USD | -14.73% |
| 2013 Q2 | 8.94 Million USD | -2.91% |
| 2013 Q1 | 9.21 Million USD | -9.08% |
| 2013 FY | 9.64 Million USD | -4.87% |
| 2013 Q4 | 9.64 Million USD | 26.39% |
| 2012 FY | 10.13 Million USD | 54.89% |
| 2012 Q1 | 7.02 Million USD | 7.41% |
| 2012 Q4 | 10.13 Million USD | 44.56% |
| 2012 Q2 | 6.66 Million USD | -5.2% |
| 2012 Q3 | 7.01 Million USD | 5.23% |
| 2011 Q1 | 7.6 Million USD | 50.62% |
| 2011 Q4 | 6.54 Million USD | -36.15% |
| 2011 Q3 | 10.24 Million USD | 5.85% |
| 2011 FY | 6.54 Million USD | 29.61% |
| 2011 Q2 | 9.68 Million USD | 27.33% |
| 2010 Q1 | 4.01 Million USD | -3.15% |
| 2010 FY | 5.04 Million USD | 21.74% |
| 2010 Q4 | 5.04 Million USD | 14.33% |
| 2010 Q3 | 4.41 Million USD | 0.03% |
| 2010 Q2 | 4.41 Million USD | 9.91% |
| 2009 Q4 | 4.14 Million USD | -6.62% |
| 2009 Q2 | 4.19 Million USD | 3.97% |
| 2009 FY | 4.14 Million USD | 8.83% |
| 2009 Q3 | 4.44 Million USD | 5.87% |
| 2009 Q1 | 4.03 Million USD | 5.88% |
| 2008 Q2 | 6.89 Million USD | -7.48% |
| 2008 Q4 | 3.81 Million USD | -6.36% |
| 2008 Q3 | 4.06 Million USD | -40.97% |
| 2008 FY | 3.81 Million USD | -50.55% |
| 2008 Q1 | 7.44 Million USD | -3.31% |
| 2007 Q1 | 2.72 Million USD | -2.37% |
| 2007 Q4 | 7.7 Million USD | 163.0% |
| 2007 Q3 | 2.92 Million USD | 8.16% |
| 2007 Q2 | 2.7 Million USD | -0.54% |
| 2007 FY | 7.7 Million USD | 176.24% |
| 2006 FY | 2.78 Million USD | -17.17% |
| 2006 Q1 | 3.5 Million USD | 4.09% |
| 2006 Q4 | 2.78 Million USD | -29.06% |
| 2006 Q2 | 3.62 Million USD | 3.41% |
| 2006 Q3 | 3.93 Million USD | 8.48% |
| 2005 Q3 | 3.73 Million USD | 3.37% |
| 2005 Q1 | 3.86 Million USD | -1.88% |
| 2005 FY | 3.36 Million USD | -14.47% |
| 2005 Q4 | 3.36 Million USD | -9.86% |
| 2005 Q2 | 3.61 Million USD | -6.45% |
| 2004 Q2 | 4.16 Million USD | 0.0% |
| 2004 FY | 3.93 Million USD | -2.17% |
| 2004 Q3 | 4.25 Million USD | 2.21% |
| 2004 Q4 | 3.93 Million USD | -7.46% |
| 2004 Q1 | 4.16 Million USD | 3.43% |
| 2003 Q3 | 3.71 Million USD | 6.22% |
| 2003 Q4 | 4.02 Million USD | 8.35% |
| 2003 Q2 | 3.49 Million USD | 9.58% |
| 2003 Q1 | 3.19 Million USD | 0.63% |
| 2003 FY | 4.02 Million USD | 26.9% |
| 2002 Q3 | 4.17 Million USD | 7.9% |
| 2002 Q1 | 3.58 Million USD | -4.45% |
| 2002 Q2 | 3.87 Million USD | 8.03% |
| 2002 FY | 3.17 Million USD | -15.44% |
| 2002 Q4 | 3.17 Million USD | -24.07% |
| 2001 FY | 3.74 Million USD | 84.45% |
| 2001 Q3 | 3.11 Million USD | 11.09% |
| 2001 Q4 | 3.74 Million USD | 20.49% |
| 2001 Q1 | 2.42 Million USD | 19.06% |
| 2001 Q2 | 2.8 Million USD | 15.73% |
| 2000 FY | 2.03 Million USD | 158.47% |
| 2000 Q1 | 941.06 Thousand USD | 0.0% |
| 2000 Q2 | 1.3 Million USD | 38.66% |
| 2000 Q4 | 2.03 Million USD | 17.48% |
| 2000 Q3 | 1.73 Million USD | 32.62% |
| 1999 FY | 786.56 Thousand USD | 39645.78% |
| 1998 FY | 1979.00 USD | 465.43% |
| 1997 FY | 350.00 USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 95.162% |
| BrainsWay Ltd. | 15.31 Million USD | 83.808% |
| Cerus Corporation | 144.3 Million USD | 98.282% |
| Envoy Medical, Inc. | 9.4 Million USD | 73.626% |
| electroCore, Inc. | 8.94 Million USD | 72.279% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | 53.582% |
| IceCure Medical Ltd | 4.24 Million USD | 41.614% |
| Inogen, Inc. | 121.38 Million USD | 97.957% |
| OrthoPediatrics Corp. | 72.56 Million USD | 96.583% |
| Lucid Diagnostics Inc. | 29.58 Million USD | 91.617% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | 22.071% |
| MaxCyte, Inc. | 36.1 Million USD | 93.132% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -34.187% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -483.062% |
| Orthofix Medical Inc. | 326.58 Million USD | 99.241% |
| PAVmed Inc | 57.13 Million USD | 95.66% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | 90.262% |
| RxSight, Inc. | 22.18 Million USD | 88.824% |
| Sight Sciences, Inc. | 46.43 Million USD | 94.66% |
| SI-BONE, Inc. | 61.05 Million USD | 95.938% |
| TELA Bio, Inc. | 59.16 Million USD | 95.809% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 97.824% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | 75.97% |
| Acutus Medical, Inc. | 54.83 Million USD | 95.478% |
| Talis Biomedical Corporation | 29.22 Million USD | 91.515% |
| Spectral AI, Inc. | 12.4 Million USD | 80.004% |
| Nano-X Imaging Ltd. | 23.13 Million USD | 89.281% |
| CVRx, Inc. | 39.28 Million USD | 93.688% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | 79.264% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -2.073% |
| Bioventus Inc. | 589.79 Million USD | 99.58% |
| Venus Concept Inc. | 107.1 Million USD | 97.685% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 95.2% |
| LivaNova PLC | 1.15 Billion USD | 99.785% |
| 908 Devices Inc. | 37.49 Million USD | 93.386% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 99.648% |
| Nemaura Medical Inc. | 26.37 Million USD | 90.599% |
| NeuroPace, Inc. | 86.99 Million USD | 97.15% |
| LENSAR, Inc. | 22.4 Million USD | 88.935% |
| Apyx Medical Corporation | 52.31 Million USD | 95.26% |
| Cutera, Inc. | 518.12 Million USD | 99.521% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | 91.545% |
| BioSig Technologies, Inc. | 4.68 Million USD | 47.073% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 95.752% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | 88.46% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 99.887% |
| Axonics, Inc. | 82.35 Million USD | 96.989% |
| Outset Medical, Inc. | 190.91 Million USD | 98.701% |
| IRIDEX Corporation | 24.91 Million USD | 90.047% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 98.0% |
| IRadimed Corporation | 20.73 Million USD | 88.042% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -48.127% |
| INVO Bioscience, Inc. | 19.99 Million USD | 87.599% |
| Telesis Bio, Inc. | 40.87 Million USD | 93.933% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 93.921% |
| Varex Imaging Corporation | 668.6 Million USD | 99.629% |
| Quipt Home Medical Corp. | 136.29 Million USD | 98.181% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | 30.581% |
| Pulmonx Corporation | 60.63 Million USD | 95.911% |
| Dynatronics Corporation | 11.78 Million USD | 78.951% |
| Modular Medical, Inc. | 2.27 Million USD | -9.14% |
| ReShape Lifesciences Inc. | 4.06 Million USD | 38.985% |
| Semler Scientific, Inc. | 6.27 Million USD | 60.452% |
| InMode Ltd. | 75.91 Million USD | 96.734% |
| Bruker Corporation | 2.83 Billion USD | 99.913% |
| Cytosorbents Corporation | 29.98 Million USD | 91.73% |
| DexCom, Inc. | 4.19 Billion USD | 99.941% |
| Align Technology, Inc. | 2.45 Billion USD | 99.899% |
| Viveve Medical, Inc. | 10.84 Million USD | 77.14% |
| ZimVie Inc. | 795.85 Million USD | 99.688% |
| Movano Inc. | 5.97 Million USD | 58.479% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 97.63% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -483.062% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | 79.264% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 99.612% |
| Profound Medical Corp. | 12.66 Million USD | 80.423% |
| Insulet Corporation | 1.85 Billion USD | 99.866% |
| enVVeno Medical Corporation | 2.43 Million USD | -1.834% |
| Surmodics, Inc. | 65.82 Million USD | 96.233% |
| iCAD, Inc. | 8 Million USD | 69.008% |
| Nuwellis, Inc. | 6.78 Million USD | 63.427% |
| Biotricity, Inc. | 35.91 Million USD | 93.097% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 98.888% |
| InspireMD, Inc. | 8.14 Million USD | 69.545% |
| PAVmed Inc. | 57.13 Million USD | 95.66% |
| BIOLASE, Inc. | 35.34 Million USD | 92.985% |
| Beyond Air, Inc. | 29.77 Million USD | 91.672% |
| FONAR Corporation | 57.45 Million USD | 95.684% |
| AxoGen, Inc. | 101.16 Million USD | 97.549% |
| Vivani Medical, Inc. | 25.03 Million USD | 90.096% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 97.176% |
| Inari Medical, Inc. | 209.32 Million USD | 98.815% |
| UFP Technologies, Inc. | 118.04 Million USD | 97.899% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | 80.461% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -13.443% |
| Tenon Medical, Inc. | 5.56 Million USD | 55.458% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -39.384% |
| Co-Diagnostics, Inc. | 17.63 Million USD | 85.938% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.921% |
| Sintx Technologies, Inc. | 6.59 Million USD | 62.39% |
| NanoVibronix, Inc. | 2.68 Million USD | 7.682% |
| Quanterix Corporation | 78.08 Million USD | 96.824% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | 30.581% |
| Sensus Healthcare, Inc. | 4.88 Million USD | 49.24% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 99.763% |
| TransMedics Group, Inc. | 568.84 Million USD | 99.564% |
| ReWalk Robotics Ltd. | 16.68 Million USD | 85.136% |
| NeuroMetrix, Inc. | 1.33 Million USD | -86.003% |
| Hyperfine, Inc. | 9.8 Million USD | 74.697% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 99.009% |
| Biomerica, Inc. | 2.66 Million USD | 6.885% |
| Bone Biologics Corporation | 831.4 Thousand USD | -198.249% |
| AVITA Medical, Inc. | 19.86 Million USD | 87.518% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -25.636% |
| Silk Road Medical, Inc | 114.15 Million USD | 97.828% |